Karin Haustermans graduated in 1987 as Doctor in Medicine, Surgery and Obstetrics (MD) at the Catholic University of Leuven (KU Leuven, Belgium). In 1993, she completed her training and qualification in Radiation Oncology. After a research fellowship at the Laboratory of Experimental Radiotherapy (KU Leuven), she obtained her PhD in Medical Sciences for which she received in 1996 the ESTRO-VARIAN Clinical Research Award. Thereafter she spent four years as a staff member at the Netherlands Cancer Institute in Amsterdam. Currently, Karin Haustermans is Medical Director of Protontherapy ParTICLe and Secretary of the Leuven Cancer Institute at the University Hospital Leuven (Belgium). She is Full Professor at the KU Leuven. She is specialized in GI and GU oncology. She is a member of several (inter)national scientific organizations. From 2006 to 2009 she held the Chair of the EORTC Radiation Oncology Group and from 2009 until 2015 she was Chair of the Quality Assurance Committee of EORTC. She is also involved in the Belgian Cancer Registry as a member of the board and chair of the Coordination Council. In 2010 she was awarded the ESTRO Breur medal in recognition of her major contribution to European Radiotherapy. From 2011 onwards she was appointed as a member of the Belgian Royal Academy of Medicine and in 2015 she became a fellow of the European Academy of Cancer Sciences. Since 2016 she is clinical editor of Radiotherapy & Oncology.

I am a Professor of Radiation Oncology, Surgery and Engineering at the Geisel School of Medicine and Thayer School of Engineering, Dartmouth College. I am a veterinarian with residency training in pathology and a PhD in radiation biology (both at Colorado State University). Post doctoral training was completed at North Carolina State University (Veterinary Radiation Oncology) and the Duke University Medical Center (Radiation Oncology). My research is focused on the preclinical study of various types radiation delivery, including hypofractionation and FLASH radiation, alone and in combination with nanotechnology, immune and chemotherapeutic agents.

Lucian Hotoiu is a Research Scientist at IBA focusing on modeling and software tools for proton therapy. He has an electrical engineering background and holds a Ph.D. in computational physical chemistry from the Vrije Universiteit Brussel (VUB – Belgium). Lucian works on FLASH using protons, including radiobiological modeling, treatment planning, designing conformal energy filters, and 3D printing them. Lucian is also a co-administrator of the open-source software tools for Proton Therapy OpenReggui (https://openreggui.org/) and MIROpt TPS for FLASH.